Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate

To compare the apparent diffusion coefficient (ADC) values of prostate cancer in both the peripheral zone (PZ) and the transition zone (TZ) with those of benign tissue in the same zone using echo‐planar diffusion weighted imaging with a parallel imaging technique.

[1]  M. Kattan,et al.  Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. , 2003, Radiology.

[2]  D. Bostwick,et al.  Prostate-specific antigen and other serum markers: current concepts from the World Health Organization Second International Consultation on Prostate Cancer. , 1999, Seminars in urologic oncology.

[3]  H. Schlemmer,et al.  Dynamic Magnetic Resonance Tomography and Proton Magnetic Resonance Spectroscopy of Prostate Cancers in Rats Treated by Radiotherapy , 2004, Investigative radiology.

[4]  Kazuto Ito,et al.  The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer. , 2003, Anticancer research.

[5]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[6]  P. Walsh Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. , 2005, The Journal of urology.

[7]  Henkjan J Huisman,et al.  Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.

[8]  J K Smith,et al.  Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. , 2001, AJNR. American journal of neuroradiology.

[9]  J C Gore,et al.  Effects of cell volume fraction changes on apparent diffusion in human cells. , 2000, Magnetic resonance imaging.

[10]  K. Sugimura,et al.  Proton two‐dimensional chemical shift imaging for evaluation of prostate cancer: External surface coil vs. endorectal surface coil , 2002, Journal of magnetic resonance imaging : JMRI.

[11]  D P Dearnaley,et al.  Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.

[12]  M. Meng,et al.  Imaging clinically localized prostate cancer. , 2003, The Urologic clinics of North America.

[13]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[14]  B. Nicolas Bloch,et al.  3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1). , 2004, Academic radiology.

[15]  T. Ichikawa,et al.  Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. , 1998, AJR. American journal of roentgenology.

[16]  C. la Vecchia,et al.  Cancer epidemiology in the elderly. , 2001, Critical reviews in oncology/hematology.

[17]  J. McNeal,et al.  Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia. , 1996, Urology.

[18]  P. Babb,et al.  Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons , 2002, BJU international.

[19]  P. Carroll,et al.  Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. , 2004, Radiology.

[20]  M. Terris,et al.  Critical evaluation of the current indications for transition zone biopsies. , 2001, Urology.

[21]  A. Hemal,et al.  Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate , 2004, Urological Research.

[22]  D. Sodickson,et al.  A generalized approach to parallel magnetic resonance imaging. , 2001, Medical physics.

[23]  P. Boesiger,et al.  SENSE‐DTI at 3 T , 2004, Magnetic resonance in medicine.

[24]  K. Taari,et al.  Prostatic MR imaging: Accuracy in differentiating cancer from other prostatic disorders , 2001, Acta radiologica.

[25]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[26]  T. Stamey,et al.  An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. , 2000, The Journal of urology.

[27]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.